Anti-Inflammatory CeO<sub>2</sub> Nanoparticles Prevented Cytotoxicity Due to Exogenous Nitric Oxide Donors via Induction Rather Than Inhibition of Superoxide/Nitric Oxide in HUVE Cells

oleh: Mohd Javed Akhtar, Maqusood Ahamed, Hisham Alhadlaq

Format: Article
Diterbitkan: MDPI AG 2021-09-01

Deskripsi

The mechanism behind the cytoprotective potential of cerium oxide nanoparticles (CeO<sub>2</sub> NPs) against cytotoxic nitric oxide (NO) donors and H<sub>2</sub>O<sub>2</sub> is still not clear. Synthesized and characterized CeO<sub>2</sub> NPs significantly ameliorated the lipopolysaccharide (LPS)-induced cytokines IL-1β and TNF-α. The main goal of this study was to determine the capacities of NPs regarding signaling effects that could have occurred due to reactive oxygen species (ROS) and/or NO, since NP-induced ROS/NO did not lead to toxicity in HUVE cells. Concentrations that induced 50% cell death (i.e., IC50s) of two NO donors (DETA-NO; 1250 ± 110 µM and sodium nitroprusside (SNP); 950 ± 89 µM) along with the IC50 of H<sub>2</sub>O<sub>2</sub> (120 ± 7 µM) were utilized to evaluate cytoprotective potential and its underlying mechanism. We determined total ROS (as a collective marker of hydrogen peroxide, superoxide radical (O<sub>2</sub><sup>•−</sup>), hydroxyl radical, etc.) by DCFH-DA and used a O<sub>2</sub><sup>•−</sup> specific probe DHE to decipher prominent ROS. The findings revealed that signaling effects mediated mainly by O<sub>2</sub><sup>•−</sup> and/or NO are responsible for the amelioration of toxicity by CeO<sub>2</sub> NPs at 100 µg/mL. The unaltered effect on mitochondrial membrane potential (MMP) due to NP exposure and, again, CeO<sub>2</sub> NPs-mediated recovery in the loss of MMP due to exogenous NO donors and H<sub>2</sub>O<sub>2</sub> suggested that NP-mediated O<sub>2</sub><sup>•−</sup> production might be extra-mitochondrial. Data on activated glutathione reductase (GR) and unaffected glutathione peroxidase (GPx) activities partially explain the mechanism behind the NP-induced gain in GSH and persistent cytoplasmic ROS. The promoted antioxidant capacity due to non-cytotoxic ROS and/or NO production, rather than inhibition, by CeO<sub>2</sub> NP treatment may allow cells to develop the capacity to tolerate exogenously induced toxicity.